Zandelisib (ME-401) is a selective, orally active, non-covalent inhibitor of PI3Kdelta. Zandelisib can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma[1].
Molecular Weight:
576.68
Purity:
99.72
CAS Number:
[1401436-95-0]
Formula:
C31H38F2N8O
Target:
Akt,PI3K
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted